KemPharm Transforms into Zevra, Focused on Advancing Rare Disease Therapeutics

KemPharm, a rare disease therapeutics company, changed its name to Zevra Therapeutics. The rebrand signifies the company’s amplified commitment and focuses towards creating innovative, patient-centred therapies for rare conditions that have limited or no existing treatments available.

Previous page Next page